In summary, our study demonstrated that the STAU2‐PALLD axis promoted the progression and metastasis of pancreatic cancer, and developed STAU2‐ASO as the first inhibitor targeting STAU2‐PALLD axis. The gene discussed is STAU2; the disease is familial pancreatic carcinoma.